Clinical Trials Browser

Phase 1/2 × Lymphoma × Biopsy, Fine-Needle × Clear all

NCT00775268 2021-03-11

18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma

Phase 1/2 Terminated

31 enrolled 18 charts

Lymphoma